271 related articles for article (PubMed ID: 17327606)
1. Tumor vascular proteins as biomarkers in ovarian cancer.
Buckanovich RJ; Sasaroli D; O'Brien-Jenkins A; Botbyl J; Hammond R; Katsaros D; Sandaltzopoulos R; Liotta LA; Gimotty PA; Coukos G
J Clin Oncol; 2007 Mar; 25(7):852-61. PubMed ID: 17327606
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of mammaglobin B in epithelial ovarian carcinomas.
Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD
Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer.
Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF
Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994
[TBL] [Abstract][Full Text] [Related]
4. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
5. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
6. The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer.
Jones MB; Michener CM; Blanchette JO; Kuznetsov VA; Raffeld M; Serrero G; Emmert-Buck MR; Petricoin EF; Krizman DB; Liotta LA; Kohn EC
Clin Cancer Res; 2003 Jan; 9(1):44-51. PubMed ID: 12538450
[TBL] [Abstract][Full Text] [Related]
7. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B
Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J
Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas.
D'Antonio A; Losito S; Pignata S; Grassi M; Perrone F; De Luca A; Tambaro R; Bianco C; Gullick WJ; Johnson GR; Iaffaioli VR; Salomon DS; Normanno N
Int J Oncol; 2002 Nov; 21(5):941-8. PubMed ID: 12370739
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes.
Bignotti E; Tassi RA; Calza S; Ravaggi A; Bandiera E; Rossi E; Donzelli C; Pasinetti B; Pecorelli S; Santin AD
Am J Obstet Gynecol; 2007 Mar; 196(3):245.e1-11. PubMed ID: 17346539
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
12. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression.
Rangel LB; Sherman-Baust CA; Wernyj RP; Schwartz DR; Cho KR; Morin PJ
Oncogene; 2003 Oct; 22(46):7225-32. PubMed ID: 14562052
[TBL] [Abstract][Full Text] [Related]
13. [Screening and identification of ovarian carcinomas related genes].
Yue W; Sun LY; Li CH; Zhang LX; Pei XT
Ai Zheng; 2004 Feb; 23(2):141-5. PubMed ID: 14960231
[TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiling of laryngeal squamous cell carcinoma by laser capture microdissection and complementary DNA microarrays.
Ma LJ; Li W; Zhang X; Huang DH; Zhang H; Xiao JY; Tian YQ
Arch Med Res; 2009 Feb; 40(2):114-23. PubMed ID: 19237021
[TBL] [Abstract][Full Text] [Related]
15. Large-scale proteomics analysis of human ovarian cancer for biomarkers.
Bengtsson S; Krogh M; Szigyarto CA; Uhlen M; Schedvins K; Silfverswärd C; Linder S; Auer G; Alaiya A; James P
J Proteome Res; 2007 Apr; 6(4):1440-50. PubMed ID: 17315909
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets.
Urzúa U; Roby KF; Gangi LM; Cherry JM; Powell JI; Munroe DJ
J Cell Physiol; 2006 Mar; 206(3):594-602. PubMed ID: 16245302
[TBL] [Abstract][Full Text] [Related]
17. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE
Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897
[TBL] [Abstract][Full Text] [Related]
18. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
[TBL] [Abstract][Full Text] [Related]
19. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
[TBL] [Abstract][Full Text] [Related]
20. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.
Le Page C; Ouellet V; Quinn MC; Tonin PN; Provencher DM; Mes-Masson AM
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):913-20. PubMed ID: 18398031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
